Review

Nature Reviews Drug Discovery 5, 37-50 (January 2006) | doi:10.1038/nrd1930

There is an Erratum (1 February 2006) associated with this article.

Epigenetic therapy of cancer: past, present and future

Christine B. Yoo1 & Peter A. Jones1  About the authors

Top

The initiation and progression of cancer is controlled by both genetic and epigenetic events. Unlike genetic alterations, which are almost impossible to reverse, epigenetic aberrations are potentially reversible, allowing the malignant cell population to revert to a more normal state. With the advent of numerous drugs that target specific enzymes involved in the epigenetic regulation of gene expression, the utilization of epigenetic targets is emerging as an effective and valuable approach to chemotherapy as well as chemoprevention of cancer.

Author affiliations

  1. USC/Norris Comprehensive Cancer Center, Department of Urology, and Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, California 90089, USA.

Correspondence to: Peter A. Jones1 Email: jones_p@ccnt.hsc.usc.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

Search PubMed for

Open Innovation Challenges

  • Mitigating Zinc Corrosion

    • Deadline: Aug 23 2009
    • Reward: $20,000 USD

    The Seeker is looking for novel methods to mitigate zinc corrosion/gassing in alkaline media. This ...

  • Plant Mitotic Arrest Agent & Protocol

    • Deadline: Jul 15 2009
    • Reward: $20,000 USD

    The Seeker is looking for an efficient chromosome doubling method in plants, particularly with respe...

naturejobs

natureproducts


Advertisement